CClinicalTrials.gg
CompletedNCT06131151Updated Sep 10, 2026

Comparison Between External Oblique Intercostal Block and Erector Spinae Plane Block in PCNL

An interventional study of External Oblique Intercostal Block and Erector Spinae Plane Block in Renal Stone, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of the study is to compare the post-operative analgesic effect of USG unilateral External oblique intercostal (EOI) block with Erector spinae plane block (ESPB) for after percutaneous Nephrolithotomy with a hypothesis that both External oblique intercostal fascial plane block and Erector spinae plane block are effective in providing postoperative analgesia.

Read the detailed description

Introduction:

Percautaneous nephrolithotomy is the tretment of choice for patients with multiple or complex kidney or upper urinary tract stones. visceral pain from the kidney and ureter and somatic pain from the incision site are the primary cause of immediate postoperative pain following PCNL. poor pain control is associated with unwanted consequences such as patient discomfort, delayed recovery, and prolonged hospital stay.

This necessitates meticulous multi-modality analgesia due to mild to moderate pain originating from renal capsule dilatation or nephrostomy tube-related stress during the first 24 h after operation. Multimodal analgesia techniques are utilized broadly to manage postoperative pain. The concept of multimodal analgesia implies not only providing analgesic drugs, but also performing nerve blocks with local anaesthetics.

first described the Erector Spinae Plane Block (ESPB), the indications and clinical use of the block for different surgical interventions have been growing. Although ESPB is interfacial plane block, anatomical studies support the idea that some of its clinical benefit may derive from spread to the paravertebral and epidural space. External oblique intercostal (EOI) block is relatively new block technique modified aiming at obtaining upper midline and lateral abdominal wall analgesia. EOI block is achived by injecting the local anesthetic solution into the fascial plane on the deep aspect of the external oblique muscle. Previous studies have hypothesized that the block succesfully anesthetized the lateral cutaneous branch and the anterior cutaneous branch of the thoracoabdominal nerves, with low pain scores and minimal narcotic use postoperatively.

Recently, there have been several publications describing external oblique nerve blocks to control post-operativte pain after abdominal surgery.

Aim of the work:

The aim of this study is to compare the post-operative analgesic effect of USG unilateral External oblique intercostal (EOI) block with Erector spinae plane block (ESPB) for after Percutaneous Nephrolithotomy with a hypothesis that both External oblique intercostal fascial plane block and Erector spinae plane block are effective in providing postoperative analgesia.

Sample size calculation:

Based on the results of a previous study, a sample size of 21 patients in each group will be calculated to detect a 20% difference in the time to first analgesic request, with alfa=0.05 and a power of 85%. Twenty-seven patients in each group will be recruited to compensate for the dropouts.

Group A: will include 27 patients, will receive External Oblique Intercostal Block.

Group B: will include 27 patients, will receive Erector Spinae Plane Block. Randomization will be performed using an online random number generator. concealment was achieved using sealed opaque envelopes.

A) Anesthesia induction:

Standard monitoring procedures will include pulse oximetry, electrocardiography, and noninvasive arterial pressure prior to anesthetic induction. All patients will be premedicated with intravenous (i.v.) midazolam 1-2 mg and antibiotic prophylaxis, according to the hospitals protocol. Anesthesia will be induced with intravenously (IV) adminestrated propofol. 2mg/kg, fentanyl 1mic/kg, and recuronium bromide 0.6 mg/kg following which endotracheal intubation will be performed. Anesthesia will be maintained with oxygen, air, and isoflurane using controlled ventilation with closed circuit in order to ensure normocarbia. At the end of the surgery, patients will receive their intervention according to gorup allocation under sterile conditions.

B) Intervention:

  1. External Oblique Intercistal Block:

    A high frequency linear ultrasound probe will be placed in a longitudinal parasagital orientation in the anterior midaxillary line. A 21G 10 cm needle will be inserted using an in-plane approach. The tip of the needle will be placed into the fascial plane on the deep aspect of the external oblique muscle. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline. ) will be injected.

  2. Erector Spinae Plane block:

A high frequency linear ultrasound probe will be placed in a longitudinal parasagital orientation 2.5-3 cm lateral to the T9 spinous process. A 21G 10 cm needle will be inserted using an in-place approach. The tip of the needle will be placed into the fascial plane on the top of the aspect of the erector spinae muscle. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline. ) will be injected.

Peimary Outcome:

The first call for rescue analgesia.

Secondary Outcome:

  1. The total analgesic requirement in 24 hours.
  2. Any adverse effects related to anesthesia or the technique.
  3. Pain scores; Numerical Rating Scales (NRS) at rest and when coughing (at 1, 2, 4, 8, 16 and 24 hours postoperatively.)
  4. Block related complications during and after block procedure till 24 hours postoperatively (local anesthetic systemic toxicity, pneumothorax and vascular puncture during block procedure).

Statistical Analysis:

Continous data with normal distribution will be compared by paired or unpaired t-tests, whereas non-normally distributed data will be assessed using the Mann- Whitney U test and Wilcoxon ranksum test for unpaired and paired results, respectively. Chi-square test or fisher's exact test will measure the association between qualitative variables.

P-valve>0.05 will be considered statistically significant.

02

Conditions studied

  • Renal Stone

Browse trials for

03

In context

Nephrolithiasis

460 studies on the registry are indexed under Nephrolithiasis; 108 are open to participants now.

This study's enrollment of 54 is below the median of 92 across 361 interventional studies indexed under Nephrolithiasis.

Browse Nephrolithiasis studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age between 18 and 65 years Body mass index of 18-35 kg/m2 Patients with the American Society of Anesthesiologists physical status I/II Patients scheduled for elective Percutaneous Nephrolithotomy Both sexes, males and females

Exclusion criteria

Exclusion Criteria:

  • Patients refusal Allergy to local anaesthetics Infection at the site of injection Coagulopathy Chronic pain syndrome Prolonged opioid medication Patients who received any analgesic 24 h befor surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    External Oblique Intercostal Block

    27 patients will receive External Oblique Intercostal Block. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.

    Procedure: External Oblique Intercostal Block

  • Experimental
    Erector Spinae Plane Block

    27 patients will receive Erector Spinae Plane Block. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.

    Procedure: Erector Spinae Plane Block

Interventions

  • ProcedureExternal Oblique Intercostal Block

    A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.

  • ProcedureErector Spinae Plane Block

    A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.

06

What researchers measure

Primary outcomes

  1. The first call for rescue analgesia after the end of the surgery

    Time frame: 24 hours

Secondary outcomes

  1. pain scores; Numerical Rating Scale (NRS)

    Numerical Rating Scale at rest and when coughing. Zero is equivalent to no pain and 10 indicates the worst possible pain.

    Time frame: 24 hours

07

Study locations

1 site
  • Faculty of Medicine, Assiut University
    Asyut, 71111, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06131151
Lead sponsor
Assiut University
Responsible party
Rehab Gomaa Ismail (Assistant Lecturer, Assiut University) — Principal investigator
First posted
Nov 14, 2023
Start date
Jan 12, 2024
Primary completion
Jan 3, 2026
Completion
Jan 3, 2026
Last update
Sep 10, 2026

Study contacts

Amr Thabet
study director · Department of anesthesia, intensive care and pain management

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion